Xentria is a venture studio that provides capital and insight into breakthrough science that aligns with our core therapeutic areas to improve the lives of patients and their families.  Since our formation in 2020, we've forged authentic partnerships to advance challenging drug development, addressing unmet needs with increased collaboration, tenacity, and partnership.  We offer holistic support, enhanced operational efficiency, and long-term partnerships to drive growth and assist in navigating challenges for an increased chance of success.

Life Sciences

Therapeutics

Venture Capital

Xentria, Inc.

Tom Shea

Victoria Cherry

Kathleen Shanahan

Tom Matthews

Noopur Singh

Lidia Gantoi

Xentria, Inc.

Org chart

Similar companies